Open-Label Placebo for Functional Dyspepsia

Stopped early · Early Phase 1 · Has a placebo group

Conditions studied: Dyspepsia

In brief

The study is evaluating the efficacy of open-label placebo for the treatment of functional dyspepsia.

Key facts

Study ID

NCT03745781

Run by

Beth Israel Deaconess Medical Center

People needed

21

Starts

2018-12-01

Expected to finish

2019-10-07

Last updated by the study team

2020-05-06

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Functional Dyspepsia

Where it is running

• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.